EBV VCA-IgG seroprevalence of 75% correlates with rising MS prevalence in MENA regions
Link Found Between Epstein-Barr Virus and Multiple Sclerosis Cases
This meta-analysis of 131 studies examines the relationship between Epstein-Barr virus (EBV) and multiple sclerosis (MS) in the MENA region.…
A large review of data from the Middle East and North Africa shows a link between rising Epstein-Barr virus rates and Multiple Sclerosis cas…
Direct-acting antiviral therapy and diverse viral infections require comprehensive epidemiological and diagnostic strategy review
Review Outlines Treatment and Prevention for Various Viral Infections
This systematic review covers the molecular biology, epidemiology, and treatment strategies for various viral infections including Hepatitis…
A comprehensive review outlines the biological traits, diagnosis methods, and treatment strategies for several common viral infections inclu…
HLA alleles and haplotypes influence the magnitude of CMV and EBV specific T-cell responses
Genetic Markers Linked to T-cell Responses Against CMV and EBV
This guideline synthesizes observational data regarding how HLA class I and II alleles, haplotypes, and HLA-G 3′UTR polymorphisms impact CMV…
Specific genetic markers may influence how the immune system responds to common viruses like CMV and EBV, potentially helping to select bett…
Narrative review on ICIs in patients with viral infections and solid tumors
Cancer Immunotherapy Works Differently in Viral Infections
This narrative review synthesizes evidence on immune checkpoint inhibitors in patients with viral infections and solid tumors.
Cancer immunotherapy can still work—and sometimes even control viruses like hepatitis or HIV—but doctors must watch for dangerous flare-ups.
Case report details antiviral and antifungal treatment in a 42-year-old male with primary HLH and EBV infection
A 42-Year-Old Man’s Fever Had a Hidden Genetic Cause
This case report with literature review describes a 42-year-old male with primary hemophagocytic lymphohistiocytosis (HLH) and Epstein–Barr …
This case shows that adults with severe infections may have a hidden genetic immune disorder, changing how doctors look for the cause.
EBV DNA positivity links to MS risk genes in a cross-ancestry study of 617,186 participants
A Common Virus May Hold the Key to MS — Here's Why
This cross-ancestry genome-wide association study analyzed 617,186 individuals to investigate the relationship between Epstein-Barr virus (E…
A virus almost everyone carries may quietly flip immune switches that set off multiple sclerosis by altering how B cells signal to T cells.
Questions about Epstein–Barr virus infection
What are the current treatment strategies for Epstein–Barr virus infection and other viral infections?
There is no single cure for Epstein-Barr virus (EBV); treatment depends on what the virus is doing, ranging from supportive care for mild illness to antivirals, immune therapies, and cancer-directed regimens for severe or EBV-linked disease [1][4][6].
Full answer →What are the treatment options for a patient with both HLH and Epstein–Barr virus infection?
Treatment for EBV-triggered HLH usually combines HLH-directed therapy (dexamethasone, etoposide, cyclosporine, or ruxolitinib) with measures to control the EBV infection and any underlying cause [6][8][10].
Full answer →